Average Co-Inventor Count = 5.25
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (9 from 4,943 patents)
2. Kind Pharmaceutical (4 from 6 patents)
3. Other (2 from 832,812 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
15 patents:
1. 12486273 - Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease
2. 12012390 - Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease
3. 11970495 - Indolizine derivatives and their application in medicine
4. 11945817 - Indolizine derivatives and their application in medicine
5. 11708344 - Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease
6. 11655249 - Indolizine derivatives and their application in medicine
7. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
8. 11021478 - Indolizine derivatives and their application in medicine
9. 10681838 - Electrical enclosure with a great heat-dissipation and an ingress protection rating equal or greater than level 65
10. 10632130 - Dehydroandrosterol and methods of using the same
11. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
12. 10611748 - Xanthone derivatives for the treatment of hepatitis B virus disease
13. 10040815 - 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
14. 10000512 - Compounds for the treatment of infectious diseases
15. 9441008 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection